The stock market is an incredible place. You will find stocks worth a few paisas all the way to shared priced over Rs 1 lakh each. However, these high prices don’t necessarily mean these stocks are expensive. Even at such astounding prices, the stock can offer good investment opportunities. 

This is what we will try and find through this article, where we will explore five of the highest-priced stocks in the market. We will see whether these highly priced stocks are still delivering or not, and most importantly, whether they are still trading cheap or not. 

Let’s begin. 

#1 MRF Limited (MRF)

Madras Rubber Factory Limited or MRF Ltd. is one of the leading tyre manufacturers in India with a market share of 30%. It offers a wide variety of tyres for different vehicles, ranging from passenger cars to trucks, tractors, two-wheelers, 3-wheelers, and more. 

While the tyre manufacturing business is the primary business segment of MRF, it also deals in sports goods, and paints. MRF also offers a wide range of services which includes pretread services that helps in increasing the shelf life of the tyres. Others include tyres and wheel-related services via different franchises such as Tirelok, T&S, MRF Fasst, Muscle Zone, Midd, and others. 

MRF is the highest priced stock in the Indian market with a share price of ₹1,49,190 (as on 10 July 2025). The market capitalization of the company is ₹63,273 crore.

So, is MRF still cheap?

Looking at the Price Earnings (P/E) ratio, the stock is trading at par with its peers. MRF’s P/E is 33.8x while the industry median PE is 33.4x. However, the company’s 10-year median PE is 24.1x, which is slightly higher than the industry number of 18.72x.  

To have a better understanding of MRF’s valuation, let’s look at the Price/Earnings to Growth (PEG) Ratio. This adjusts the valuation for the earnings growth of the company. A lower value indicates the stock’s undervaluation given the future growth prospects.

MRF has the highest PEG ratio of 5.87 amongst its peers. The industry median PEG ratio is 1.33, making MRF quite expensive in comparison. 

Coming to the financials, sales of MRF Tyres increased from ₹19,317 crore in FY22 to ₹28,153 crore in FY25, registering a compound annual growth rate (CAGR) of 13%. The net profit jumped from ₹669 crore in FY22 to ₹1,869 crore in FY25, at a CAGR of 50%. The return on capital employed (ROCE) also jumped from 6% in FY22 to 14% in FY25. 

Though the stock is trading at a premium currently, it is delivering growth in terms of both sales and profits. The share price has increased by 12.02% in the past 1-year, and 6.90% in the last 30 days.

#2 Page Industries Limited (PAGEIND)

Page Industries Ltd. is the exclusive licensee of two globally recognised brands – Jockey and Speedo. It takes care of the entire business of these two brands, starting from manufacturing to marketing of the products. It has a wide network of 3,986 distributors globally, with a retail network of 110,176 stores. There are around 1,436 exclusive brand stores as well, and more. 

The stock is currently trading at ₹48,245 per share, and the market capitalization is ₹53,739 crore (as on 10 July 2025). Let’s see whether this stock is cheap or not. 

The stock is trading at a PE of 73.7x, way higher compared to the industry median PE of 32.9x. Its 10-year median PE of 74.04x is almost triple of the industry number of 25.44x. Even the PEG ratio tells the same story. The industry PEG ratio is just 1, while this company has a PEG ratio of 4.53, highest amongst its peers, making the company appear expensive in comparison. It must be said that atleast part of the premium the company commands could be attributed to the unassailable moat it has built over the years. 

The sales of the company rose from ₹3,886 crore in FY22 to ₹4,935 crore in FY25, growing at 8% CAGR. During the same period, the profit increased from ₹537 crore to ₹729 crore, at an 11% CAGR. However, Page Industries witnessed a fall in its ROCE during the period. It went down from 67% in FY22 to 59% in FY25. 

In the last one year, Page Industries’ share price increased by 22.44%, while in the past one month, it increased by 3.23%. 

#3 Honeywell Automation India Limited (HONAUT)

Honeywell Automation India Ltd. is a leading integrated automation solutions provider. It offers automation solutions and control systems for a wide range of businesses. 

The Product Solutions it offers cater to the enhancement in productivity of business operations across industries like oil & gas, pulp and paper, refining, and industrial power. Then its Sensing Solutions includes various humidity and temperature sensors for various controls used across healthcare facilities, the transportation sector, the defence sector, aerospace, and more. It also offers Building Solutions for the maintenance of infrastructure and their safety. 

Honeywell India has a market cap of ₹35,929 Crore, and the current share price is ₹40,635, the third-highest-priced stock in the market. So, is this automation giant trading cheap or expensive?

Currently, the PE ratio of the stock is 68.6x, which is almost double the industry median PE of 37.7x..The 10-year median PE of the stock is 66.4x which is also way higher than industry figure of 26.9x. 

Honeywell’s PEG ratio is currently at 53.5. It is way higher than the industry median PEG ratio of 1.2, making the stock appear quite expensive.   

Even though the company’s valuation is what it is, it is delivering fairly. The sales of the automation giant increased from ₹2,948 crore in FY22 to ₹4,190 crore in FY25, increasing at a 12% CAGR. The net profit jumped 16% CAGR during this period from ₹339 crore in FY22 to ₹524 crore in FY25. However, the ROCE increased just marginally from 17% in FY22 to 18% in FY25. 

The stock dipped almost 30% in the past one year while in the last one month, it gained around 3.81%.

#4 BOSCH Limited (BOSCHLTD)

Bosch Ltd. is a well-known name in the technology space offering automotive solutions, industrial technology, building technology and even consumer goods. It develops and trades gasoline and diesel fuel injection systems, industrial equipment, security systems, electrical power tools, automotive aftermarket products, and more. 

At a share price of ₹36,195, it is the fourth-highest-priced stock in India, with a market capitalization of ₹1,06,721 crore. So, is the stock still cheap and has room for a price rise?

The current PE of the stock is 53x, almost double the industry median PE of 28.7x. Even the 10-year median PE of the stock is 40.1x way higher than the industry number of 23.93x. Coming to the Bosch’s PEG ratio, which is 4.2, way higher than the industry median PEG of 0.96 making the stock quite expensive compared to its peers. 

The stock is trading at a premium perhaps due to the company’s solid delivery. In the past three years, it has delivered some solid growth. The sales jumped from ₹11,782 crore in FY22 to ₹18,087 crore in FY25, registering a 15% CAGR. The net profit grew by 18% CAGR during the same period. It went up from ₹1,217 crore in FY22 to ₹2,013 crore in FY25. Even the ROCE increased from 15% in FY22 to 21% in FY25. 

In the past one year, the Bosch share price rose around 4.28% while in the past one month, it jumped 16.63%. 

#5 Abbott India Limited (ABBOTINDIA)

Abbott India Ltd. is a leading pharmaceutical company in India with over 125 products for different health issues. The firm has a huge network of distributors and stockists in India and also exports the products to Sri Lanka, Nepal, Bhutan, and Maldives. The manufacturing facility of the firm is located in Goa.

The stock is currently trading at ₹34,420 per share and has a market capitalization of ₹73,024. Let’s find out if this stock is cheap or at a premium.

The PE of the stock is 51.63x, higher than the industry median PE of 33.5. Even the 10-year median PE of the stock is 47.34x, higher than the industry figure of 27.42x. The PEG ratio is 2.72 while the industry median is 1.02, and all these indicate that the stock is trading at a premium.

The strong delivery by the pharma giant might be a reason for its stock trading at a premium. The sales of the company increased from ₹4,913 crore in FY22 to ₹6,409 crore in FY25, at a 9% CAGR. The net profit jumped at a CAGR of 21% during the same period from ₹799 crore to ₹1,414 crore. The company also witnessed a growing ROCE, from 38% in FY22 to 46% in FY25.

The share price of Abbott India grew by 23.60% during the past one year, while in the past one month, it increased by 8.74%. 

Wrapping up 

So, while most of these highest-priced stocks in India may not be that cheap anymore, they are still delivering. Whether it is their sales or the profits, both are growing over the years. This growth, even when the shares are so highly priced, makes these stocks quite interesting. It will be interesting to see if these stocks ever become cheaper in the future. Or then they continue to break the high price barrier, disregarding the already high valuations.  

We have relied on data from www.Screener.in throughout this article. Only in cases where the data was not available, have we used an alternate, but widely used and accepted source of information. 

The purpose of this article is only to share interesting charts, data points and thought-provoking opinions. It is NOT a recommendation. If you wish to consider an investment, you are strongly advised to consult your advisor. This article is strictly for educative purposes only. 

Maumita Mitra is a seasoned writer specializing in demystifying the world of investment for a broad audience. She has a keen eye for detail and a knack for explaining complex financial concepts in the simplest manner possible. 

Disclosure: The writer and his dependents do not hold the stocks discussed in this article. 

The website managers, its employee(s), and contributors/writers/authors of articles have or may have an outstanding buy or sell position or holding in the securities, options on securities or other related investments of issuers and/or companies discussed therein.  The content of the articles and the interpretation of data are solely the personal views of the contributors/ writers/authors.  Investors must make their own investment decisions based on their specific objectives, resources and only after consulting such independent advisors as may be necessary.